Study links common drugs to a lower level of prostate-specific antigen

08/8/2010 | HealthDay News

Commonly used drugs such as painkillers and statins might cause errors in diagnostic tests for prostate cancer because they appear to reduce the level of prostate-specific antigen, researchers reported. "If future studies show that the difference in [prostate-specific antigen] has no bearing on the development of prostate cancer, then it may be necessary to lower the [prostate-specific antigen] threshold for recommending prostate needle biopsies in men who are taking [nonsteroidal anti-inflammatory drugs], statins and thiazide diuretics," the study's lead author said.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA